Kevin Oboyle - Jul 22, 2025 Form 3 Insider Report for CARLSMED, INC. (CARL)

Role
Director
Signature
/s/ Leonard Greenstein, as attorney-in-fact for Kevin O'Boyle
Stock symbol
CARL
Transactions as of
Jul 22, 2025
Transactions value $
$0
Form type
3
Date filed
7/22/2025, 05:30 PM
Previous filing
Jul 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OBOYLE KEVIN C Director C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD /s/ Leonard Greenstein, as attorney-in-fact for Kevin O'Boyle 2025-07-22 0001203567

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CARL Stock Option (Right to Buy) Jul 22, 2025 Common Stock 104K $2.23 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 103,702 unvested stock options convertible into approximately 103,702 shares of the Issuer's common stock, which began to vest on September 20, 2024, subject to a one-year cliff, and will be fully vested on September 20, 2028. These options are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split").
F2 The exercise price has been adjusted to reflect the Reverse Split.